NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 878 filers reported holding NOVARTIS A G in Q2 2016. The put-call ratio across all filers is 1.16 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,481,871 | +17.8% | 34,183 | +16.7% | 0.00% | +33.3% |
Q2 2023 | $2,955,250 | +769.2% | 29,286 | +713.5% | 0.00% | – |
Q4 2020 | $340,000 | -86.2% | 3,600 | -87.9% | 0.00% | -100.0% |
Q2 2016 | $2,465,000 | +13.9% | 29,873 | 0.0% | 0.01% | 0.0% |
Q1 2016 | $2,164,000 | -13.5% | 29,873 | +2.8% | 0.01% | -12.5% |
Q4 2015 | $2,501,000 | -1.0% | 29,073 | +5.8% | 0.01% | -11.1% |
Q3 2015 | $2,525,000 | -6.6% | 27,473 | 0.0% | 0.01% | 0.0% |
Q2 2015 | $2,702,000 | -28.8% | 27,473 | -28.6% | 0.01% | -18.2% |
Q1 2015 | $3,793,000 | +1.8% | 38,462 | -4.3% | 0.01% | 0.0% |
Q4 2014 | $3,726,000 | +4.7% | 40,210 | +6.4% | 0.01% | 0.0% |
Q3 2014 | $3,558,000 | +4.0% | 37,795 | 0.0% | 0.01% | +10.0% |
Q2 2014 | $3,422,000 | +5.6% | 37,795 | -0.8% | 0.01% | 0.0% |
Q1 2014 | $3,239,000 | +8.0% | 38,095 | +2.1% | 0.01% | +11.1% |
Q4 2013 | $2,998,000 | +107.0% | 37,295 | +97.6% | 0.01% | +125.0% |
Q3 2013 | $1,448,000 | +66.8% | 18,870 | +53.8% | 0.00% | +33.3% |
Q2 2013 | $868,000 | – | 12,270 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |